Kamps B S, Brodt H R, Staszewski S, Bergmann L, Helm E B
Medizinische Klinik III, Universitätsklinik Frankfurt, Germany.
Clin Investig. 1994 Mar;72(4):283-7. doi: 10.1007/BF00180041.
The clinical history of 1538 HIV positive patients was analyzed on the basis of the new CDC classification system of HIV disease and AIDS. This classification system combines three CD4 cell categories (1, 2, and 3) with three clinical categories (A, B, and C) into nine subgroups A1-C3. We examined the overall survival for all subgroups and the AIDS-free survival for subgroups A1-B3. AIDS-free survival for patients in subgroups A1, A2, and B1 was considerably longer than survival in patients from subgroups A3, B2, and B3 (P < 0.0001). According to these findings, the new CDC classification system could be simplified into three stages, stage I and II comprising the above mentioned six subgroups, and stage III comprising clinical AIDS defining categories C1, C2, and C3. These three stages correspond to different periods in the management of HIV positive patients, i.e., period of observation, period of prophylaxis, and period of treatment.
根据美国疾病控制与预防中心(CDC)新的HIV疾病和艾滋病分类系统,对1538例HIV阳性患者的临床病史进行了分析。该分类系统将三个CD4细胞类别(1、2和3)与三个临床类别(A、B和C)合并为九个亚组A1 - C3。我们检查了所有亚组的总生存率以及A1 - B3亚组的无艾滋病生存率。A1、A2和B1亚组患者的无艾滋病生存率明显长于A3、B2和B3亚组患者的生存率(P < 0.0001)。根据这些发现,新的CDC分类系统可简化为三个阶段,第一阶段和第二阶段包括上述六个亚组,第三阶段包括定义为临床艾滋病的C1、C2和C3类别。这三个阶段对应于HIV阳性患者管理的不同时期,即观察期、预防期和治疗期。